US$14 b is AU$160 per share for Neuren.I think you are right that similar deal would be reasonable for Neuren in not too distant future.
Analysts estimated $2 billion peak sales potential for Karuna drug for Schizophrenia if approved.
Trof peak sales likely $1 billion now and NNZ-2591 for 4 current Ph 2 indications been said to be 5x market size ie $5 billion. Which is 2.5x for Karuna drug.They just completed Ph 3 of course, and we are still Ph 2. But if you add a 60% discount for that you'd end up same place as Karuna.
I personally believe any takeover will be over 100. And if Neuren keep pushing it could be $150 or more potentially.
- Forums
- ASX - By Stock
- NEU
- Bristol Myers to acquire Karuna for $14Billion
Bristol Myers to acquire Karuna for $14Billion, page-5
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.00 |
Change
-0.560(3.85%) |
Mkt cap ! $1.806B |
Open | High | Low | Value | Volume |
$14.38 | $14.42 | $13.94 | $3.660M | 258.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 69 | $14.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.01 | 789 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 69 | 14.000 |
4 | 53 | 13.990 |
3 | 590 | 13.980 |
5 | 856 | 13.970 |
4 | 821 | 13.960 |
Price($) | Vol. | No. |
---|---|---|
14.010 | 808 | 13 |
14.020 | 803 | 6 |
14.030 | 1003 | 7 |
14.040 | 889 | 5 |
14.050 | 754 | 5 |
Last trade - 14.56pm 04/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |